{"d":{"__metadata":{"id":"https://ws.parlament.ch/OData.svc/Business(ID=20135200,Language='DE')","uri":"https://ws.parlament.ch/OData.svc/Business(ID=20135200,Language='DE')","type":"itsystems.Pd.DataServices.DataModel.Business"},"BusinessResponsibilities":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20135200,Language='DE')/BusinessResponsibilities"}},"RelatedBusinesses":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20135200,Language='DE')/RelatedBusinesses"}},"BusinessRoles":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20135200,Language='DE')/BusinessRoles"}},"Publications":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20135200,Language='DE')/Publications"}},"LegislativePeriods":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20135200,Language='DE')/LegislativePeriods"}},"Sessions":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20135200,Language='DE')/Sessions"}},"Preconsultations":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20135200,Language='DE')/Preconsultations"}},"Bills":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20135200,Language='DE')/Bills"}},"Councils":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20135200,Language='DE')/Councils"}},"BusinessTypes":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20135200,Language='DE')/BusinessTypes"}},"Votes":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20135200,Language='DE')/Votes"}},"SubjectsBusiness":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20135200,Language='DE')/SubjectsBusiness"}},"BusinessStates":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20135200,Language='DE')/BusinessStates"}},"Council":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20135200,Language='DE')/Council"}},"Transcripts":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20135200,Language='DE')/Transcripts"}},"ID":20135200,"Language":"DE","BusinessShortNumber":"13.5200","BusinessType":14,"BusinessTypeName":"Fragestunde. Frage","BusinessTypeAbbreviation":"Fra.","Title":"Medikamentensicherheit","Description":null,"InitialSituation":null,"Proceedings":null,"DraftText":null,"SubmittedText":"<p>Die Schweiz kennt Regeln der vereinfachten Zulassung von Arzneimitteln. Laut Studien steigern Ibuprofen und Diclofenac das Herzinfarktrisiko ebenso wie damals Vioxx, das in der EU erheblich fr\u00fcher vom Markt genommen wurde als in der Schweiz.</p><p>1. Pr\u00fcft Swissmedic, die beiden Entz\u00fcndungshemmer vom Markt zu nehmen?</p><p>2. Orientiert sie sich wie bei der Zulassung an der EU, um im Gleichschritt die Mittel vom Markt zu nehmen?</p><p>3. Nach welchen Regeln richtet sich der Bund, um riskante Medikamente vom Markt zu nehmen?</p>","ReasonText":null,"DocumentationText":null,"MotionText":null,"FederalCouncilResponseText":null,"FederalCouncilProposal":null,"FederalCouncilProposalText":null,"FederalCouncilProposalDate":null,"SubmittedBy":"Heim Bea","BusinessStatus":229,"BusinessStatusText":"Erledigt","BusinessStatusDate":"\/Date(1370822400000)\/","ResponsibleDepartment":4,"ResponsibleDepartmentName":"Departement des Innern","ResponsibleDepartmentAbbreviation":"EDI","IsLeadingDepartment":true,"Tags":"2841","Category":null,"Modified":"\/Date(1690543304720)\/","SubmissionDate":"\/Date(1370390400000)\/","SubmissionCouncil":1,"SubmissionCouncilName":"Nationalrat","SubmissionCouncilAbbreviation":"NR","SubmissionSession":4909,"SubmissionLegislativePeriod":49,"FirstCouncil1":null,"FirstCouncil1Name":null,"FirstCouncil1Abbreviation":null,"FirstCouncil2":null,"FirstCouncil2Name":null,"FirstCouncil2Abbreviation":null,"TagNames":"Gesundheit"}}